Crinetics terminates ATM sales agreement effective Vertex merger closing
Crinetics Pharmaceuticals terminated its at-the-market equity Sales Agreement with SVB Leerink and Cantor Fitzgerald, effective at the merger closing with Vertex. The agreement was dated June 21, 2024.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.